dr. A.M.E. (Annemiek) Walenkamp
Medical Oncologist (MD)
Telephone:
E-mail:
a.walenkamp umcg.nl
Research
Research units:
- de Hosson, L. D. (2019). Neuroendocrine tumors; measures to improve treatment and supportive care. [Groningen]: Rijksuniversiteit Groningen.
- Bouma, G. (2019). The web around patients with neuroendocrine tumors: novel ways to inform, support and treat. [Groningen]: Rijksuniversiteit Groningen. https://doi.org/10.33612/diss.98868349
- Westerink, N-D. L. (2018). Long-term adverse effects of cancer treatment: Susceptibility and intervention strategies. [Groningen]: Rijksuniversiteit Groningen.
- den Hollander, M. W. (2015). Targeted therapy, molecular imaging and biomarkers in cancer treatment: Getting more personalized. [Groningen]: University of Groningen.
- Boer, J. (2015). Targeting FPR1 and CXCR4 in cancer and the contribution of the tumor microenvironment. [Groningen]: University of Groningen.
- Tamas, K. R. (2015). Targets in the microenvironment of rectal cancer: A focus on angiogenic growth factors and chemokines. [Groningen]: University of Groningen.
- Kruizinga, R. (2014). Role of VEGFA, CXCR4 and VHL mutation in tumour behaviour. [S.l.]: s.n.
- Domanska, U. M. (2013). Tumor microenvironment: preclinical insights into therapy resistance and targeting strategies. Groningen: s.n.
ID: 393545